TY - JOUR
T1 - Loss of inverse association between framingham risk score and estimated glomerular filtration rate in moderate to severe diabetic kidney disease
AU - Khaloo, Pegah
AU - Alemi, Hamid
AU - Mansournia, Mohammad Ali
AU - Rabizadeh, Soghra
AU - Salehi, Salome Sadat
AU - Blaha, Michael J.
AU - Mirbolouk, Mohammad Hassan
AU - Mirmiranpour, Hossein
AU - Esteghamati, Alireza
AU - Nakhjavani, Manouchehr
N1 - Publisher Copyright:
© 2019 The Author(s).
PY - 2019/2
Y1 - 2019/2
N2 - Background: We investigated the association of estimated glomerular filtration rate (eGFR) with Framingham risk score (FRS), and actual cardiovascular disease (CVD) in patients with type 2 diabetes (T2DM). We also assessed improvement in FRS for prediction of CVD after inclusion of eGFR and albuminuria. Methods: A total of 571 patients with T2DM and mean age 55 were divided into 2 groups based on the presence of CVD. Participants without CVD were then divided into three groups according to FRS. CVD is defined as an episode of CCU admission, Myocardial infarction, history of coronary artery bypass graft surgery or percutaneous intervention. FRS is calculated using the Wilson 1998 Circulation equation, which includes age, sex, high blood pressure, smoking, high-density lipoprotein (HDL), total cholesterol and diabetes as components to assess CVD risk in 10 years. Results: An inverse adjusted association between eGFR and prevalent CVD was confirmed by multiple logistic regression analysis (OR = 0.84, 95% CI: 0.74, 0.94, P = 0.03). We observed every 10 mL/min/1.73 m2 decrease in eGFR is related to 3% increase in FRS in patients without chronic kidney disease (CKD) (coefficient =-0.03, P < 0.001). The association between FRS and GFR and also CVD and eGFR were not significant in patients with CKD (P = 0.12; P = 0.17, respectively). Predictive values for FRS components with and without considering eGFR and albuminuria were calculated (0.74 and 0.75, respectively). Conclusion: Inclusion of eGFR and albuminuria in the FRS formula did not improve the predictive value of the model. We showed an inverse association between eGFR and FRS in early stages of diabetic kidney disease, which was lost in patients with CKD.
AB - Background: We investigated the association of estimated glomerular filtration rate (eGFR) with Framingham risk score (FRS), and actual cardiovascular disease (CVD) in patients with type 2 diabetes (T2DM). We also assessed improvement in FRS for prediction of CVD after inclusion of eGFR and albuminuria. Methods: A total of 571 patients with T2DM and mean age 55 were divided into 2 groups based on the presence of CVD. Participants without CVD were then divided into three groups according to FRS. CVD is defined as an episode of CCU admission, Myocardial infarction, history of coronary artery bypass graft surgery or percutaneous intervention. FRS is calculated using the Wilson 1998 Circulation equation, which includes age, sex, high blood pressure, smoking, high-density lipoprotein (HDL), total cholesterol and diabetes as components to assess CVD risk in 10 years. Results: An inverse adjusted association between eGFR and prevalent CVD was confirmed by multiple logistic regression analysis (OR = 0.84, 95% CI: 0.74, 0.94, P = 0.03). We observed every 10 mL/min/1.73 m2 decrease in eGFR is related to 3% increase in FRS in patients without chronic kidney disease (CKD) (coefficient =-0.03, P < 0.001). The association between FRS and GFR and also CVD and eGFR were not significant in patients with CKD (P = 0.12; P = 0.17, respectively). Predictive values for FRS components with and without considering eGFR and albuminuria were calculated (0.74 and 0.75, respectively). Conclusion: Inclusion of eGFR and albuminuria in the FRS formula did not improve the predictive value of the model. We showed an inverse association between eGFR and FRS in early stages of diabetic kidney disease, which was lost in patients with CKD.
KW - Cardiovascular disease
KW - Diabetic nephropathy
KW - EGFR
KW - Framingham risk score
KW - Type 2 diabetes
UR - http://www.scopus.com/inward/record.url?scp=85064841833&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064841833&partnerID=8YFLogxK
M3 - Article
C2 - 30980645
AN - SCOPUS:85064841833
SN - 1029-2977
VL - 22
SP - 91
EP - 98
JO - Archives of Iranian medicine
JF - Archives of Iranian medicine
IS - 2
ER -